A Safety Study of IMOVAX Polio Vaccine in Selected Cities in China
NCT01278433
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
5007
Enrollment
INDUSTRY
Sponsor class
Conditions
Polio
Poliomyelitis
Interventions
BIOLOGICAL:
IMOVAX Polio™: Inactivated Poliomyelitis Vaccine
Sponsor
Sanofi Pasteur, a Sanofi Company